Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Bullboard Posts
Comment by PulcanFan88on Jan 25, 2019 3:51pm
52 Views
Post# 29283046

RE:RE:RE:RE:Was in the PP at 3.35$$

RE:RE:RE:RE:Was in the PP at 3.35$$

Why are you obsessed with MISLEADING investors

Having production dosen't means sales. You can produce 1 billion tons of cannabis, but at the end of the day, someone need to buy this so you can't call it a ''SALE'' LOL.

You say you know nothing, but in fact it's you who know's NOTHING

Their press release on 16th January says they have 40 millions CASH (again you mislead investors with 50 millions).

Stop Lying. Stop spreading fasle lies to recoup your loses, this is grossly overpriced and your misleading investors so you can recoup your loses probably at 10$/shares. Anyone who have 100 IQ and over will do a spread sheet, compare with ICC and Khiron, and notice on every comparison basis, PCLO is majorly overvalued.

You are suggesting growing outdoor marjiuana = sales. IT'S not. It require a certain quality and MAINLY, a buyer, which Pharmacielo dosen't have at the present time

Please, get back to the basic and for the sake of Stockhouse relevance, stop lying about PCLO, you cannot expect reality when you uses pink glasses and don't compare to peers.



Cheers

JFR1611 wrote: Pulcan, you know nothing

the cash position is $50M
the burn rate is $1,6M/ mo
they are producing on 5,8 hectares ( little less than 600,000 sq feet, 2x higher that the production in October) only that is $100M revenues 
the run Arte for the year is 10 hectares of production or $200M of revenus
theuy regeustered 30 strains months ago and they should get the final approbation for their sakes licence in February which will be the first cannabis to receive such licence in Colombia 

if if you don't know the story, now you know

those who are shorting the stock: GOOD LUCK

 

Bullboard Posts